Greene Barry E bought DYN
June 22, 2026 · Form 4 insider transaction
Greene Barry E bought 57,463 shares of Dyne Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
57,463
Price
$0.00
Total value
N/A
InsiderGreene Barry E
RoleOfficer, Director
SecurityStock option (right to buy)
Transaction codeA: Grant or award
Transaction dateJune 22, 2026
Filing dateJune 23, 2026
Shares owned after57,463
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The option was granted on June 22, 2026. The shares underlying the option are scheduled to vest over three years in equal monthly installments through June 22, 2029.